Core Insights - The article discusses the shift in investor focus towards companies with sustainable earnings power, indicating that future market returns will be driven by fundamentals rather than hype [1][2] Group 1: Market Trends - Investors are increasingly looking for a broader market rally beyond technology stocks, with industrials, healthcare, and small-cap companies expected to lead [2][3] - There is a growing caution among investors regarding high tech valuations, allowing other sectors to gain traction [3] Group 2: Stock Selection Methodology - Stocks considered for analysis have market capitalizations exceeding $2 billion, with a focus on those forecasted to have EPS growth over the next 5 years and a return on equity above 20% [5] - The stocks are ranked based on the number of hedge fund holdings, utilizing Insider Monkey's database as of Q3 2025 [5][6] Group 3: Company Highlights - ServiceNow, Inc. (NYSE:NOW) has a return on equity of 16.81% and is projected to have an upside potential of 68% with a price target of $200 [8] - Micron Technology, Inc. (NASDAQ:MU) has a return on equity of 22.55%, with a price target raised to $385 from $330, indicating strong demand for generative AI and a potential upcycle extending into 2027 [12][13][14]

Group 1: Stock Performance - Nike, Inc. (NYSE:NKE) decreased by 12.81% due to a 17% decline in Greater China sales in Q2 and multiple analysts lowering their price forecasts [1] - Arm Holdings plc (NASDAQ:ARM) fell by 9.77% after Goldman Sachs downgraded the stock from Neutral to Sell, lowering the price forecast from $160 to $120, and B of A Securities reduced it from $205 to $145 [2] - Insmed Incorporated (NASDAQ:INSM) decreased by 11.37% this week [3] - ServiceNow, Inc. (NYSE:NOW) fell by 0.78% after the Phase 2b BiRCh study did not meet its efficacy endpoints [3] - BitMine Immersion Technologies, Inc. (AMEX:BMNR) decreased by 9.15% amid volatility in Bitcoin prices [4] - Lennar Corporation (NYSE:LEN) fell by 9.94% following a fourth-quarter earnings miss and multiple analysts lowering their price forecasts [4] - Coupang, Inc. (NYSE:CPNG) decreased by 8.52% this week [4] - Marathon Petroleum Corporation (NYSE:MPC) slumped by 9.42% due to a CFO transition announcement [4] - Entegris, Inc. (NASDAQ:ENTG) fell by 5.90% after Goldman Sachs downgraded the stock from Neutral to Sell, lowering the price target from $88 to $75 [5] - Phillips 66 (NYSE:PSX) fell by 8.84% as energy stocks traded lower due to Russia-Ukraine ceasefire hopes affecting oil prices and warmer weather forecasts impacting natural gas [5]

Group 1: ServiceNow, Inc. - Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, expressed a favorable view on ServiceNow, Inc. (NYSE:NOW), noting a year-to-date decline of 14% in its stock price [1] - Morgan Stanley analyst Keith Weiss upgraded ServiceNow from Equal-Weight to Overweight on September 24, increasing the price target from $1,040 to $1,250 [1] Group 2: Vertex Pharmaceuticals Inc - Jim Lebenthal, partner at Cerity Partners, highlighted Vertex Pharmaceuticals Inc (NASDAQ:VRTX) for its strong drug profile [2] - Citigroup analyst Geoff Meacham maintained a Buy rating for Vertex Pharmaceuticals on October 2, raising the price target from $550 to $575 [3] - Vertex Pharmaceuticals received FDA Breakthrough designation for Povetacicept in IgAN, completed AMKD trial enrollment, and launched an ADPKD study, aiming for first-in-class kidney therapies [3] Group 3: iShares Core S&P Small-Cap ETF - Shannon Saccocia, chief investment officer of NB Private Wealth, identified iShares Core S&P Small-Cap ETF (NYSE:IJR) as her final trade [1]